Compliance Rate
Compliance Rate
36.36%
Compliant submissions
8
Incompliant submissions
14
Total trials
22
My Organizations' Clinical Trials
Showing 750 of 1641 entries
View as:
Phase: N/A
Priority: Normal
Start: 06/06/25
End: 11/01/27
Due: 11/01/28
Phase: N/A
Priority: Normal
Start: 02/28/10
End: 12/31/14
Due: 12/31/15
Phase: N/A
Priority: Normal
Start: 09/01/22
End: 09/22/23
Due: 09/22/24
Phase: N/A
Priority: Normal
Start: 09/30/12
End: 07/31/15
Due: 07/31/16
Phase: N/A
Priority: Normal
Start: 12/31/14
End: 11/30/15
Due: 11/30/16
Phase: N/A
Priority: Normal
Start: 12/31/99
End: 06/30/05
Due: 06/30/06
Phase: N/A
Priority: Normal
Start: 09/30/07
End: 03/31/10
Due: 03/31/11
Phase: N/A
Priority: Normal
Start: 01/10/12
End: 07/17/17
Due: 07/17/18
Phase: N/A
Priority: Normal
Start: 03/31/07
End: 08/31/13
Due: 08/31/14
Phase: N/A
Priority: Normal
Start: 07/08/19
End: 03/28/24
Due: 03/28/25
Phase: N/A
Priority: Normal
Start: 06/30/13
End: 12/31/14
Due: 12/31/15
Phase: N/A
Priority: Normal
Start: 12/05/16
End: 10/21/22
Due: 10/21/23
Phase: N/A
Priority: Normal
Start: 09/01/20
End: 06/30/26
Due: 06/30/27
Phase: N/A
Priority: Normal
Start: 11/01/16
End: 06/30/19
Due: 06/30/20
Phase: N/A
Priority: Normal
Start: 11/24/20
End: 01/31/22
Due: 01/31/23
Phase: N/A
Priority: Normal
Start: 01/31/17
End: 01/29/21
Due: 01/29/22
Phase: N/A
Priority: Normal
Start: 12/01/17
End: 06/30/22
Due: 06/30/23
Phase: N/A
Priority: Normal
Start: 04/30/06
End: 06/30/16
Due: 06/30/17
Phase: N/A
Priority: Normal
Start: 03/31/12
End: 07/31/16
Due: 07/31/17
Phase: N/A
Priority: Normal
Start: 04/05/20
End: 08/17/22
Due: 08/17/23
Phase: N/A
Priority: Normal
Start: 01/31/17
End: 11/30/17
Due: 11/30/18
Phase: N/A
Priority: Normal
Start: 07/31/02
End: 11/30/04
Due: 11/30/05
Phase: N/A
Priority: Normal
Start: 12/30/19
End: 01/08/24
Due: 01/08/25
Phase: N/A
Priority: Normal
Start: 04/30/10
End: 07/31/12
Due: 07/31/13
Effectiveness of Lofexidine to Prevent Stress-Related Opiate Relapse During Naltrexone Treatment - 1
Phase: N/A
Priority: Normal
Start: 02/28/05
End: 01/31/09
Due: 01/31/10